<?xml version="1.0" encoding="UTF-8"?><!-- generator="WordPress/2.6.1" -->
<rss version="0.92">
<channel>
	<title>Medical Sales Jobs Websites</title>
	<link>http://medical-sales-jobs-websites.com</link>
	<description>Medical Sales Jobs &#124; Laboratory Sales Jobs &#124; Medical Device Sales Jobs</description>
	<lastBuildDate>Thu, 11 Mar 2010 13:06:08 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	
	<item>
		<title>New Hip Implant Provides Personalized Fit</title>
		<description>Zimmer Introduces the Continuum(TM) Acetabular System WARSAW, Ind., March 11 (HSMN NewsFeed) -- Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH), a leader in musculoskeletal care, today showcased its recently introduced Continuum Acetabular Cup System at t... Devices, OrthopaedicZimmer Holdings, Continuum Acetabular Cup, total hip New Hip Implant Provides Personalized Fit
			 </description>
		<link>http://medical-sales-jobs-websites.com/2010/03/new-hip-implant-provides-personalized-fit/</link>
			</item>
	<item>
		<title>New Introducer Product Line from St. Jude Laboratory Offers Reliable Access and Facilitates Arterial Closure</title>
		<description>Engage Family offers physicians state-of-the-art introducers capable of facilitating both femoral and radial access ST. PAUL, Minn.--(HSMN NewsFeed)--St. Jude Clinical, Inc. (NYSE:STJ ) today announced U.S. Food and Drug Administration (FDA) clearance an... Devices, Interventional, FDA, RegulatorySt. Jude Medical, Engage TR Introducer, Engage Introducer New Introducer Product Line from St. ...</description>
		<link>http://medical-sales-jobs-websites.com/2010/03/new-introducer-product-line-from-st-jude-medical-offers-reliable-access-and-facilitates-arterial-closure/</link>
			</item>
	<item>
		<title>Smith and Nephew Announces Next Steps in Patent Infringement Litigation</title>
		<description>ST. PETERSBURG, Fla., March 10 (HSMN NewsFeed) -- The Advanced Wound Management division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew plc. (LSE: SN; NYSE: SNN), notes the decision returned today by a jury in the patent litigation brought by Ki... Devices, Wound Care, LitigationSmith & Nephew, ...</description>
		<link>http://medical-sales-jobs-websites.com/2010/03/smith-and-nephew-announces-next-steps-in-patent-infringement-litigation/</link>
			</item>
	<item>
		<title>ETEX Corporation Announces FDA Clearance and Launch of Carrigen(R) Porous Bone Substitute Material</title>
		<description>Carrigen(R) Porous Bone Substitute Material - The First Hard Setting, Highly Porous Bone Graft Substitute CAMBRIDGE, Mass., March 9 (HSMN NewsFeed) --ETEX Corporation, an advanced biomaterials company, announced today that the FDA has granted 510(k) c... Devices, Orthopaedic, FDAETEX Corp, CarriGen, Bone Substitute ETEX Corporation Announces FDA Clearance and Launch ...</description>
		<link>http://medical-sales-jobs-websites.com/2010/03/etex-corporation-announces-fda-clearance-and-launch-of-carrigenr-porous-bone-substitute-material/</link>
			</item>
	<item>
		<title>Positron Corporation Cites JACR Study That Reports a 737% Growth Rate in PET among 5 Speciality Groups Including Cardiology</title>
		<description>INDIANAPOLIS--(HSMN NewsFeed)--Positron Corporation (OTCBB:POSC ). The growth rate among nonradiologists who own or lease PET equipment was far higher than radiologists between 2002 and 2007, according to a study published in the March issue of the Journal... Devices, Radiology, Oncology, CardiologyPositron Corp, positron emission tomography, PET imaging Positron Corporation Cites ...</description>
		<link>http://medical-sales-jobs-websites.com/2010/03/positron-corporation-cites-jacr-study-that-reports-a-737-growth-rate-in-pet-among-5-speciality-groups-including-cardiology/</link>
			</item>
	<item>
		<title>Medifocus, Inc. Announces That It Has Received Approval to Initiate Its Pivotal Phase III Clinical Trial for Treatment of Breast Cancer from the Food and Drug Administration (FDA), Investigational Device Exemption (IDE) Application</title>
		<description>VANCOUVER, British Columbia--(HSMN NewsFeed)--Medifocus Inc. (OTC:MDFZF.PK and TSXV:MFS) is pleased to announce that it has received from the Food and Drug Administration (FDA) an Investigational Device Exemption (IDE) approval to initiate a pivotal Phase ... Devices, Oncology, FDAMedifocus, Microfocus, hyperthermia therapy, breast cancer Medifocus, Inc. Announces That It Has Received ...</description>
		<link>http://medical-sales-jobs-websites.com/2010/03/medifocus-inc-announces-that-it-has-received-approval-to-initiate-its-pivotal-phase-iii-clinical-trial-for-treatment-of-breast-cancer-from-the-food-and-drug-administration-fda-investigational-dev/</link>
			</item>
	<item>
		<title>Orthopaedic Synergy, Inc. Announces Letter of Intent to Acquire Praxim, SA</title>
		<description>EAST TAUNTON, Mass., March 9 (HSMN NewsFeed) -- Orthopaedic Synergy, Inc., is pleased to announce that it has entered into a letter of intent and period of exclusivity to acquire Praxim, SA of France. &#34;The acquisition of Praxim SA will represe... Devices, Orthopaedic, Mergers & AcquisitionsOrthopaedic Synergy, Praxim Orthopaedic Synergy, ...</description>
		<link>http://medical-sales-jobs-websites.com/2010/03/orthopaedic-synergy-inc-announces-letter-of-intent-to-acquire-praxim-sa/</link>
			</item>
	<item>
		<title>X-spine Announces Exclusive License with Gamma Spine for Minimally-Invasive Spinal Technology</title>
		<description>MIAMISBURG, Ohio--(HSMN NewsFeed)--X-spine Systems, Inc., a global manufacturer of implants and instruments for spinal surgery, announced today that it has entered into an exclusive license agreement with Gamma Spine for the development and distribution of... Devices, Orthopaedic, Neurosurgery, LicensingX-spine Systems, Gamma Spine X-spine Announces Exclusive License with Gamma Spine for ...</description>
		<link>http://medical-sales-jobs-websites.com/2010/03/x-spine-announces-exclusive-license-with-gamma-spine-for-minimally-invasive-spinal-technology/</link>
			</item>
	<item>
		<title>Varian Clinical Systems Names Dr. John Adler as Chief of New Clinical Applications</title>
		<description>PALO ALTO, Calif., March 8 (HSMN NewsFeed) -- Varian Clinical laboratory Systems (NYSE:VAR ) today announced that it has appointed John R. Adler, Jr., M.D., as Vice President and Chief of New Medical Applications for the company. Dr. Adler, a renowned neurosurgeon... Devices, Oncology, Neurosurgery, PersonnelVarian Clinical Systems, Accuray, radiotherapy, ...</description>
		<link>http://medical-sales-jobs-websites.com/2010/03/varian-medical-systems-names-dr-john-adler-as-chief-of-new-clinical-applications/</link>
			</item>
	<item>
		<title>NxStage Announces New FREEDOM Data Showing the Positive Impact of its Every day Home Hemodialysis Therapy on Sleep Quality and Restless Legs Syndrome</title>
		<description>LAWRENCE, Mass. and SEATTLE, March 8 (HSMN NewsFeed) -- Booths # 23-25 at the Annual Dialysis Conference -- NxStage Pharmaceutical, Inc. (Nasdaq:NXTM ), a big manufacturer of innovative dialysis products, today announced the latest interim results from its ... DevicesNxStage Clinical, home hemodialysis, hemodialysis, Restless Legs Syndrome NxStage Announces New ...</description>
		<link>http://medical-sales-jobs-websites.com/2010/03/nxstage-announces-new-freedom-data-showing-the-positive-impact-of-its-daily-home-hemodialysis-therapy-on-sleep-quality-and-restless-legs-syndrome/</link>
			</item>
</channel>
</rss>
